H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | 2 | $177,550 | $175,100 - $180,000 | 100.0% |
| AstraZeneca Pharmacetuicals LP | 1 | $135,239 | $135,239 - $135,239 | 100.0% |
| BLUEPRINT MEDICINES CORPORATION | 1 | $208,035 | $208,035 - $208,035 | 100.0% |
| Celgene Corporation | 1 | $175,000 | $175,000 - $175,000 | 100.0% |
| Nurix Therapeutics | 1 | $165,000 | $165,000 - $165,000 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 5 | $175,100 | $165,000 - $208,035 |
| Unspecified | 1 | $135,239 | $135,239 - $135,239 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Cambridge | MA | 1 | $208,035 |
| Madison | NJ | 1 | $175,100 |
| Princeton | NJ | 1 | $180,000 |
| San Francisco | CA | 1 | $165,000 |
| South San Francisco | CA | 1 | $135,239 |
| Summit | NJ | 1 | $175,000 |
These roles are variations of Associate Director, Pharmacovigilance Scientist with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Associate Director, Pharmacovigilance Scientist | 5 | $180,627 | |
| Associate Pharmacovigilance Scientist | Unspecified | 3 | $131,746 |
| ASSOCIATE DIRECTOR, PHARMACOVIGILANCE (PV) SCIENTIST | 2 | $152,500 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 1 | $135,239 | 100.0% |
| 2022 | 1 | $175,000 | 100.0% |
| 2023 | 1 | $180,000 | 100.0% |
| 2024 | 1 | $175,100 | 100.0% |
| 2025 | 2 | $186,518 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | 2 | $177,550 | 100.0% |
| AstraZeneca Pharmacetuicals LP | 1 | $135,239 | 100.0% |
| BLUEPRINT MEDICINES CORPORATION | 1 | $208,035 | 100.0% |
| Celgene Corporation | 1 | $175,000 | 100.0% |
| Nurix Therapeutics | 1 | $165,000 | 100.0% |